12.INCOME TAXES

Provision for Income Taxes and Effective Tax Rate

The following table provides the components of income (loss) before provision for income taxes from continuing operations by domestic and foreign subsidiaries:

Year Ended December 31,

2025

2024

2023

Domestic

($ 31,404)

($ 24,479)

$ 431

Foreign

11,170

8,762

3,086

Total

($ 20,234)

($ 15,717)

$ 3,517

The components of the income tax (benefit) expense from continuing operations are as follows:

Year Ended December 31,

  ​ ​ ​

2025

2024

2023

Current:

Federal

($ 59)

$ 408

$ 301

State

374

1,211

795

Foreign

3,576

3,060

1,789

Total current income tax provision

3,891

4,679

2,885

Deferred

Federal

(1,709)

(2,277)

(1,137)

State

(458)

(573)

(903)

Foreign

756

(758)

(861)

Total deferred income tax benefit

(1,411)

(3,608)

(2,901)

Total income tax (benefit) expense from continuing operations

$ 2,480

$ 1,071

($ 16)

The reconciliation of the provision for income tax (benefit) expense from continuing operations at the United States federal statutory rate compared to the Company's income tax (benefit) expense as reported is as follows, with reconciling items for all periods presented disaggregated by nature and jurisdiction in accordance with the retrospective adoption of ASU 2023-09, Improvements to Income Tax Disclosures, effective January 1, 2025:

Year Ended December 31,

2025

2024

2023

  ​ ​ ​

Amount

Percent

Amount

Percent

Amount

Percent

U.S. Federal Statutory Tax Rate

($ 4,249)

21.00%

($ 3,302)

21.00%

$ 739

21.00%

State and Local Income Taxes, Net of Federal Effect(a)

137

(0.68)%

815

(5.18)%

558

15.87%

Foreign Tax Effects

1,861

(9.20)%

951

(6.05)%

(409)

(11.66)%

Canada

Foreign Rate Differential

512

(2.53)%

327

(2.08)%

668

18.98%

Stock Based Compensation

81

(0.40)%

149

(0.95)%

(446)

(12.68)%

Adjustment to Deferred Tax Assets

875

(4.33)%

(17)

0.11%

157

4.46%

Other

-

0.00%

-

0.00%

1

0.01%

Other Foreign Jurisdictions

393

(1.94)%

492

(3.13)%

(789)

(22.44)%

Effect of Changes in Tax Laws or Rates

-

0.00%

-

0.00%

-

0.00%

Effect of Cross-Border Tax

-

0.00%

-

0.00%

-

0.00%

Tax Credits

431

(2.13)%

(2,576)

16.38%

(1,903)

(54.10)%

Research and Development Tax Credit

431

(2.13)%

(2,576)

16.38%

(1,903)

(54.10)%

Change of Valuation Allowance

-

0.00%

-

0.00%

-

0.00%

Nontaxable or Nondeductible Items

4,077

(20.15)%

4,617

(29.37)%

(373)

(10.61)%

Fines/Penalties

345

(1.70)%

-

0.00%

-

0.00%

Non-deductible Legal Settlement

630

(3.11)%

-

0.00%

-

0.00%

Stock Compensation

3,305

(16.34)%

4,675

(29.74)%

(375)

(10.66)%

Other

(203)

1.00%

(58)

0.37%

2

0.05%

Changes in Unrecognized Tax Benefits

217

(1.07)%

652

(4.14)%

475

13.53%

Other

6

(0.03)%

(86)

0.55%

897

25.50%

Effective Tax Rate

2,480

(12.26)%

1,071

(6.81)%

(16)

(0.47)%

(a)State taxes in Texas and California made up the majority (greater than 50 percent) of the tax effect in this category

The following table provides the income taxes paid, net of refunds received, disaggregated by federal, state, and foreign jurisdictions in accordance with ASU 2023-09:

Year Ended December 31,

2025

2024

2023

Federal

$ 166

$ 608

$ -

State

947

401

831

Foreign

3,484

1,685

1,900

Total

$ 4,597

$ 2,694

$ 2,731

Income taxes paid (net of refunds) exceeded 5% of total income taxes paid (net of refunds) in the following jurisdictions:

Year Ended December 31,

2025

2024

2023

State

Texas

$ 322

$ 230

$ 390

Foreign

Canada

$ 2,990

$ 1,612

$ 1,887

The Company has adjusted prior year amounts to remove amounts from discontinued operations.

Deferred tax assets and liabilities from continuing operations consist of the following for the periods presented:

  ​ ​ ​

December 31, 2025

December 31, 2024

Deferred tax assets:

Net operating loss carryforward

$ 30,238

$ 26,110

Accruals and Reserves

8,392

11,252

Goodwill and Intangibles

984

1,887

Research and Experimental Costs

22,138

19,331

Research and Development Credit

4,605

4,973

Share-based compensation

14,814

14,685

Total gross deferred tax assets

81,171

78,238

Less: Valuation allowance

(542)

(158)

Deferred tax assets, net of valuation allowance

80,629

78,080

Deferred tax liabilities:

Property and equipment

(3,476)

(2,659)

Other

357

353

Total gross deferred tax liabilities

(3,119)

(2,306)

Net deferred tax assets

$ 77,510

$ 75,774

The Company accounts for deferred taxes under ASC Topic 740 – Income Taxes (“ASC 740”), which requires a reduction of the carrying amount of deferred tax assets by a valuation allowance if, based on available evidence, it is more likely than not that such assets will not be realized. Accordingly, the need to establish valuation allowances for deferred tax assets is assessed periodically based on the ASC 740 more-likely-than-not realization threshold criterion. This assessment considers matters such as future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. The evaluation of the recoverability of the deferred tax assets requires that the Company weigh all positive and negative evidence to reach a conclusion that it is more likely than not that all or some portion of the deferred tax assets will not be realized. The weight given to the evidence is commensurate with the extent to which it can be objectively verified. As of December 31, 2025, based on its assessment of the realizability of its net deferred tax assets, the Company concluded that its U.S. federal, and the majority of its foreign net deferred tax assets will more-likely-than-not be fully realized, however certain U.S. State and foreign deferred tax assets will likely not be fully realized.

As of December 31, 2025, the Company had federal, state and foreign net operating losses of approximately $110.9, $84.8 and $11.3, respectively. The full amount of $110.9 of federal net operating loss can be carried forward indefinitely and can offset 80% of future taxable income. Certain state net operating losses will carry forward for a limited number of years and, if not utilized, may begin to expire in 2031. As of December 31, 2025, the Company determined that $14.5 of state net operating loss (“NOL”) will likely expire and recorded $0.3 of valuation allowance. Certain foreign net operating losses will carry forward for a limited number of years and, if not utilized, will begin to expire in 2029. As of December 31, 2025, the Company determined that $1.0 of foreign NOL will likely expire and recorded $0.2 million of valuation allowance. The Company conducted an IRC Section 382 analysis with respect to its net operating loss carryforward and determined there was an immaterial limitation.

Undistributed earnings of the Company’s foreign subsidiaries are considered to be indefinitely reinvested and accordingly, no provision for applicable income taxes has been provided thereon. Upon distribution of those earnings, the Company would be subject to withholding taxes payable to various foreign countries. As of December 31, 2025 the undistributed earnings of the Company's foreign subsidiaries could result in withholding taxes of approximately $1.2, if repatriated.

As of December 31, 2025, the Company had federal and California Research and Development credit carryforwards of approximately $6.3 and $0.8, respectively. The federal credit can be carried forward 20 years and will begin to expire in 2039. The California credit can be carried forward indefinitely.

Uncertain Tax Positions

The Company maintains liabilities for uncertain tax positions. These liabilities involve considerable judgment and estimation and are continuously monitored by management based on the best information available, including changes in tax regulations, the outcome of relevant court cases, and other information. A reconciliation of the beginning and ending amount of gross unrecognized benefits is as follows:

Year Ended December 31,

2025

2024

2023

Unrecognized tax benefits - beginning of year

$ 2,573

$ 1,904

$ 1,309

Gross increase for tax positions of prior years

(450)

(39)

63

Gross increase for tax positions of current year

278

708

532

Unrecognized tax benefits - end of year

$ 2,401

$ 2,573

$ 1,904

The unrecognized tax benefits relate to federal and California R&D credits are generated from 2019 through 2025. The total amount of unrecognized tax benefits that would affect the Company's effective tax rate, if recognized, is $2,401 and $2,573 at December 31, 2025 and 2024, respectively. The Company's policy is to recognize interest and penalties related to income tax matters in income tax expense. As of December 31, 2025 and 2024, the Company did not accrue interest or penalties related to uncertain tax positions. The company does not expect any of the uncertain tax positions to reverse during the next 12 months.

There are no federal or state tax examinations in progress. Because the Company has net operating loss carryforwards, there are open statutes of limitations in which federal taxing authorities may examine the Company's tax returns for all years from December 31, 2012 through the current period. U.S. State taxing authorities may examine the Company's tax returns for all years from December 31, 2015 through the current period and foreign tax authorities may examine the Company's tax return for all years from December 31, 2020 through the current period.

The Company is subject to a wide variety of tax laws and regulations across the jurisdictions where it operates. Regulatory developments from the U.S. or international tax reform legislation could result in an impact to the Company's effective tax rate. On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted into U.S. law. In accordance with ASC 740, the Company evaluated the impact of the legislation on its financial statements, including potential changes to deferred tax assets and liabilities, and the effective tax rate. The Company determined that OBBBA did not have a material impact on its consolidated financial statements. The Company continues to monitor the Base Erosion and Profit Shifting (BEPS) Integrated Framework provided by the Organization for Economic Co-operation and Development (OECD) including the legislative adoption of Pillar I and II by countries, and all other tax regulatory changes, to evaluate the potential impact on future periods. The adoption of Pillar Two rules did not have a significant impact on the Company's consolidated financial statements in 2025.

Free Sentinel

Want the next AGNT, Inc. income taxes disclosure the moment it drops?

Set a Sentinel and we'll alert you the moment AGNT, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.

Track for free

Historical Timeline

Fiscal YearFiled
2025Feb 24, 2026Showing above
2024Feb 20, 2025
2023Feb 22, 2024
2022Feb 28, 2023
2021Feb 25, 2022
2020Mar 11, 2021
2019Mar 12, 2020
2018Mar 18, 2019
2017Apr 17, 2018
2016Mar 31, 2017
2015Mar 15, 2016

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.